<main class="html-publication" lang="en" role="main">
      

  <div class="publication-external">
    <ul class="organisation-logos">
        <li class="organisation-logos__logo">
          
<div class="gem-c-organisation-logo brand--department-for-environment-food-rural-affairs">
    <a class="gem-c-organisation-logo__container gem-c-organisation-logo__link gem-c-organisation-logo__crest gem-c-organisation-logo__crest--single-identity brand__border-color" href="/government/organisations/veterinary-medicines-directorate">
      <span class="gem-c-organisation-logo__name">Veterinary <br>Medicines <br>Directorate</span>
</a>
</div>
        </li>
    </ul>
  </div>

  <header class="gem-c-inverse-header  gem-c-inverse-header--padding-top ">
    
  

<div class="gem-c-title gem-c-title--inverse govuk-!-margin-top-8 govuk-!-margin-bottom-0">
      <span class="govuk-caption-xl gem-c-title__context">
    Guidance
  </span>


  <h1 class="gem-c-title__text govuk-heading-xl">
    Glossary
  </h1>
</div>
  <p class="publication-header__last-changed">Updated 8 June 2022</p>

  </header>




<div class="govuk-grid-row sidebar-with-body" data-module="sticky-element-container">
    <div class="govuk-grid-column-one-quarter-from-desktop contents-list-container">
        <nav aria-label="Contents" class="gem-c-contents-list" data-module="gem-track-click" role="navigation">
    <h2 class="gem-c-contents-list__title">
      Contents
</h2>
    <ol class="gem-c-contents-list__list">
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 1" data-track-category="contentsClicked" data-track-label="#adverse-event" data-track-options="{&quot;dimension29&quot;:&quot;\n1. Adverse event&quot;}" href="#adverse-event"><span class="gem-c-contents-list__number">1. </span><span class="gem-c-contents-list__numbered-text">Adverse event</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 2" data-track-category="contentsClicked" data-track-label="#adverse-reaction" data-track-options="{&quot;dimension29&quot;:&quot;\n2. Adverse reaction&quot;}" href="#adverse-reaction"><span class="gem-c-contents-list__number">2. </span><span class="gem-c-contents-list__numbered-text">Adverse reaction</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 3" data-track-category="contentsClicked" data-track-label="#animals-managed-and-treated-as-a-group" data-track-options="{&quot;dimension29&quot;:&quot;\n3. Animals managed and treated as a group&quot;}" href="#animals-managed-and-treated-as-a-group"><span class="gem-c-contents-list__number">3. </span><span class="gem-c-contents-list__numbered-text">Animals managed and treated as a group</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 4" data-track-category="contentsClicked" data-track-label="#cascade-use" data-track-options="{&quot;dimension29&quot;:&quot;\n4. Cascade use&quot;}" href="#cascade-use"><span class="gem-c-contents-list__number">4. </span><span class="gem-c-contents-list__numbered-text">Cascade use</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 5" data-track-category="contentsClicked" data-track-label="#centrally-authorised-product-cap" data-track-options="{&quot;dimension29&quot;:&quot;\n5. Centrally Authorised Product (CAP)&quot;}" href="#centrally-authorised-product-cap"><span class="gem-c-contents-list__number">5. </span><span class="gem-c-contents-list__numbered-text">Centrally Authorised Product (CAP)</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 6" data-track-category="contentsClicked" data-track-label="#clinical-trial" data-track-options="{&quot;dimension29&quot;:&quot;\n6. Clinical Trial&quot;}" href="#clinical-trial"><span class="gem-c-contents-list__number">6. </span><span class="gem-c-contents-list__numbered-text">Clinical Trial</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 7" data-track-category="contentsClicked" data-track-label="#competent-authority-ca" data-track-options="{&quot;dimension29&quot;:&quot;\n7. Competent Authority (CA)&quot;}" href="#competent-authority-ca"><span class="gem-c-contents-list__number">7. </span><span class="gem-c-contents-list__numbered-text">Competent Authority (CA)</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 8" data-track-category="contentsClicked" data-track-label="#data-lock-point-dlp" data-track-options="{&quot;dimension29&quot;:&quot;\n8. Data Lock Point (DLP)&quot;}" href="#data-lock-point-dlp"><span class="gem-c-contents-list__number">8. </span><span class="gem-c-contents-list__numbered-text">Data Lock Point (DLP)</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 9" data-track-category="contentsClicked" data-track-label="#detailed-description-of-a-pharmacovigilance-system-ddps" data-track-options="{&quot;dimension29&quot;:&quot;\n9. Detailed Description of a Pharmacovigilance System (DDPS)&quot;}" href="#detailed-description-of-a-pharmacovigilance-system-ddps"><span class="gem-c-contents-list__number">9. </span><span class="gem-c-contents-list__numbered-text">Detailed Description of a Pharmacovigilance System (DDPS)</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 10" data-track-category="contentsClicked" data-track-label="#eu-birth-date-ebd" data-track-options="{&quot;dimension29&quot;:&quot;\n10. EU Birth Date (EBD)&quot;}" href="#eu-birth-date-ebd"><span class="gem-c-contents-list__number">10. </span><span class="gem-c-contents-list__numbered-text">EU Birth Date (EBD)</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 11" data-track-category="contentsClicked" data-track-label="#the-european-medicines-agency-ema" data-track-options="{&quot;dimension29&quot;:&quot;\n11. The European Medicines Agency (EMA)&quot;}" href="#the-european-medicines-agency-ema"><span class="gem-c-contents-list__number">11. </span><span class="gem-c-contents-list__numbered-text">The European Medicines Agency (EMA)</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 12" data-track-category="contentsClicked" data-track-label="#expedited-report" data-track-options="{&quot;dimension29&quot;:&quot;\n12. Expedited report&quot;}" href="#expedited-report"><span class="gem-c-contents-list__number">12. </span><span class="gem-c-contents-list__numbered-text">Expedited report</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 13" data-track-category="contentsClicked" data-track-label="#harmonised-birth-date-hbd" data-track-options="{&quot;dimension29&quot;:&quot;\n13. Harmonised Birth Date (HBD)&quot;}" href="#harmonised-birth-date-hbd"><span class="gem-c-contents-list__number">13. </span><span class="gem-c-contents-list__numbered-text">Harmonised Birth Date (HBD)</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 14" data-track-category="contentsClicked" data-track-label="#human-adverse-reaction" data-track-options="{&quot;dimension29&quot;:&quot;\n14. Human adverse reaction&quot;}" href="#human-adverse-reaction"><span class="gem-c-contents-list__number">14. </span><span class="gem-c-contents-list__numbered-text">Human adverse reaction</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 15" data-track-category="contentsClicked" data-track-label="#international-birth-date-ibd" data-track-options="{&quot;dimension29&quot;:&quot;\n15. International Birth Date (IBD)&quot;}" href="#international-birth-date-ibd"><span class="gem-c-contents-list__number">15. </span><span class="gem-c-contents-list__numbered-text">International Birth Date (IBD)</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 16" data-track-category="contentsClicked" data-track-label="#international-cooperation-on-harmonisation-of-technical-requirements-for-registration-of-veterinary-medicinal-products-vich" data-track-options="{&quot;dimension29&quot;:&quot;\n16. International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH)&quot;}" href="#international-cooperation-on-harmonisation-of-technical-requirements-for-registration-of-veterinary-medicinal-products-vich"><span class="gem-c-contents-list__number">16. </span><span class="gem-c-contents-list__numbered-text">International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH)</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 17" data-track-category="contentsClicked" data-track-label="#lack-of-expected-efficacy" data-track-options="{&quot;dimension29&quot;:&quot;\n17. Lack of expected efficacy&quot;}" href="#lack-of-expected-efficacy"><span class="gem-c-contents-list__number">17. </span><span class="gem-c-contents-list__numbered-text">Lack of expected efficacy</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 18" data-track-category="contentsClicked" data-track-label="#marketing-authorisation-ma" data-track-options="{&quot;dimension29&quot;:&quot;\n18. Marketing Authorisation (MA)&quot;}" href="#marketing-authorisation-ma"><span class="gem-c-contents-list__number">18. </span><span class="gem-c-contents-list__numbered-text">Marketing Authorisation (MA)</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 19" data-track-category="contentsClicked" data-track-label="#marketing-authorisation-holder-mah" data-track-options="{&quot;dimension29&quot;:&quot;\n19. Marketing Authorisation Holder (MAH)&quot;}" href="#marketing-authorisation-holder-mah"><span class="gem-c-contents-list__number">19. </span><span class="gem-c-contents-list__numbered-text">Marketing Authorisation Holder (MAH)</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 20" data-track-category="contentsClicked" data-track-label="#national-competent-authority-nca" data-track-options="{&quot;dimension29&quot;:&quot;\n20. National Competent Authority (NCA)&quot;}" href="#national-competent-authority-nca"><span class="gem-c-contents-list__number">20. </span><span class="gem-c-contents-list__numbered-text">National Competent Authority (NCA)</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 21" data-track-category="contentsClicked" data-track-label="#off-label-use" data-track-options="{&quot;dimension29&quot;:&quot;\n21. Off-label use&quot;}" href="#off-label-use"><span class="gem-c-contents-list__number">21. </span><span class="gem-c-contents-list__numbered-text">Off-label use</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 22" data-track-category="contentsClicked" data-track-label="#post-marketing-surveillance-studies" data-track-options="{&quot;dimension29&quot;:&quot;\n22. Post-marketing surveillance studies&quot;}" href="#post-marketing-surveillance-studies"><span class="gem-c-contents-list__number">22. </span><span class="gem-c-contents-list__numbered-text">Post-marketing surveillance studies</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 23" data-track-category="contentsClicked" data-track-label="#primary-data" data-track-options="{&quot;dimension29&quot;:&quot;\n23. Primary data&quot;}" href="#primary-data"><span class="gem-c-contents-list__number">23. </span><span class="gem-c-contents-list__numbered-text">Primary data</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 24" data-track-category="contentsClicked" data-track-label="#pharmacovigilance-system-master-file-psmf" data-track-options="{&quot;dimension29&quot;:&quot;\n24. Pharmacovigilance System Master File (PSMF)&quot;}" href="#pharmacovigilance-system-master-file-psmf"><span class="gem-c-contents-list__number">24. </span><span class="gem-c-contents-list__numbered-text">Pharmacovigilance System Master File (PSMF)</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 25" data-track-category="contentsClicked" data-track-label="#periodic-safety-update-report-psur" data-track-options="{&quot;dimension29&quot;:&quot;\n25. Periodic Safety Update Report (PSUR)&quot;}" href="#periodic-safety-update-report-psur"><span class="gem-c-contents-list__number">25. </span><span class="gem-c-contents-list__numbered-text">Periodic Safety Update Report (PSUR)</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 26" data-track-category="contentsClicked" data-track-label="#psur-abridged" data-track-options="{&quot;dimension29&quot;:&quot;\n26. PSUR, abridged&quot;}" href="#psur-abridged"><span class="gem-c-contents-list__number">26. </span><span class="gem-c-contents-list__numbered-text">PSUR, abridged</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 27" data-track-category="contentsClicked" data-track-label="#serious-adverse-event" data-track-options="{&quot;dimension29&quot;:&quot;\n27. Serious adverse event&quot;}" href="#serious-adverse-event"><span class="gem-c-contents-list__number">27. </span><span class="gem-c-contents-list__numbered-text">Serious adverse event</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 28" data-track-category="contentsClicked" data-track-label="#serious-adverse-reaction" data-track-options="{&quot;dimension29&quot;:&quot;\n28. Serious adverse reaction&quot;}" href="#serious-adverse-reaction"><span class="gem-c-contents-list__number">28. </span><span class="gem-c-contents-list__numbered-text">Serious adverse reaction</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 29" data-track-category="contentsClicked" data-track-label="#summary-of-product-characteristics-spc" data-track-options="{&quot;dimension29&quot;:&quot;\n29. Summary of Product Characteristics (SPC)&quot;}" href="#summary-of-product-characteristics-spc"><span class="gem-c-contents-list__number">29. </span><span class="gem-c-contents-list__numbered-text">Summary of Product Characteristics (SPC)</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 30" data-track-category="contentsClicked" data-track-label="#unexpected-adverse-event" data-track-options="{&quot;dimension29&quot;:&quot;\n30. Unexpected adverse event&quot;}" href="#unexpected-adverse-event"><span class="gem-c-contents-list__number">30. </span><span class="gem-c-contents-list__numbered-text">Unexpected adverse event</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 31" data-track-category="contentsClicked" data-track-label="#unexpected-adverse-reaction" data-track-options="{&quot;dimension29&quot;:&quot;\n31. Unexpected adverse reaction&quot;}" href="#unexpected-adverse-reaction"><span class="gem-c-contents-list__number">31. </span><span class="gem-c-contents-list__numbered-text">Unexpected adverse reaction</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 32" data-track-category="contentsClicked" data-track-label="#veterinary-dictionary-for-drug-regulatory-activities-veddra" data-track-options="{&quot;dimension29&quot;:&quot;\n32. Veterinary Dictionary for Drug Regulatory Activities (VeDDRA)&quot;}" href="#veterinary-dictionary-for-drug-regulatory-activities-veddra"><span class="gem-c-contents-list__number">32. </span><span class="gem-c-contents-list__numbered-text">Veterinary Dictionary for Drug Regulatory Activities (VeDDRA)</span></a>

        </li>
        <li class="gem-c-contents-list__list-item gem-c-contents-list__list-item--numbered">
          <a class="gem-c-contents-list__link govuk-link govuk-link--no-underline" data-track-action="content_item 33" data-track-category="contentsClicked" data-track-label="#veterinary-medicine" data-track-options="{&quot;dimension29&quot;:&quot;\n33. Veterinary Medicine&quot;}" href="#veterinary-medicine"><span class="gem-c-contents-list__number">33. </span><span class="gem-c-contents-list__numbered-text">Veterinary Medicine</span></a>

        </li>
    </ol>
</nav>
      
<div class="gem-c-print-link govuk-!-display-none-print govuk-!-margin-top-0 govuk-!-margin-bottom-6">
    <button class="govuk-link govuk-body-s gem-c-print-link__button" data-module="print-link">Print this page</button>
</div>
    </div>

  <div class="print-wrapper">
    <div class="print-meta-data">
      <p>
  <img class="print-meta-data-licence" src="/assets/government-frontend/open-government-licence-min-93b6a51b518ff99714a1aa2a7d2162735c155ec3cb073c75fb88b2a332fa83d3.png">
</p>
<p>
  © Crown copyright 2022
</p>
<p>
  This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit <a href="https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3">nationalarchives.gov.uk/doc/open-government-licence/version/3</a> or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: <a href="mailto:psi@nationalarchives.gov.uk">psi@nationalarchives.gov.uk</a>.
</p>
<p>
  Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
</p>
<p>
  This publication is available at https://www.gov.uk/government/publications/pharmacovigilance-of-veterinary-medicines-in-great-britain/glossary
</p>


    </div>
  </div>

  <div class="main-content-container">
    <div class="gem-c-govspeak-html-publication">
  
<div class="gem-c-govspeak govuk-govspeak " data-module="govspeak">
    
    
      <div class="govspeak">
<h2>
<span class="number">1. </span>Adverse event</h2>
<p>Any observation in animals, whether or not considered to be product-related, that is unfavourable and unintended and that occurs after any use of a veterinary medicine (off-label and on-label uses). Included are events related to a suspected lack of expected efficacy according to approved labelling or noxious reactions in humans after being exposed to a veterinary medicine(s). Ref. <a class="govuk-link" href="https://vichsec.org/en/guidelines/pharmacovigilance/vich-gls-24-29-35-42.html" rel="external">VICH GL 24</a> (Pharmacovigilance: AERs).</p>

<h2>
<span class="number">2. </span>Adverse reaction</h2>
<p>A reaction to a veterinary medicinal product that is harmful and unintended and that occurs at doses normally used in animals for the prophylaxis, diagnosis or treatment of disease or to restore, correct or modify a physiological function. Ref. <a class="govuk-link" href="https://www.legislation.gov.uk/uksi/2013/2033/schedule/1/part/8" rel="external">The Veterinary Medicines Regulations 2013, Part 1, Part 8</a>. This guidance will not include the word ”suspected” when making full text reference to adverse reactions, serious adverse reactions or human adverse reactions.</p>

<h2>
<span class="number">3. </span>Animals managed and treated as a group</h2>
<p>Animals in intensive food animal production concerning species such as poultry, fish or bees which are managed and treated as a group. In these situations, a certain level of mortality rate is considered as ‘normal’ or ‘expected’. These species are usually treated as a group/flock and only an increase of mortality rate, or severe signs, or animal production losses exceeding the rates normally expected should be considered as serious.</p>

<h2>
<span class="number">4. </span>Cascade use</h2>
<p>Veterinary medicines are authorised for specific conditions for specific target species, based on assessed data. The conditions of use for each authorised veterinary medicine are listed in its Summary of Product Characteristics (SPC). The VMD’s <a class="govuk-link" href="https://www.vmd.defra.gov.uk/ProductInformationDatabase/" rel="external">Product Information Database</a> contains the SPCs of all veterinary medicines authorised in the UK. Where there is no clinically suitable veterinary medicine authorised in the United Kingdom for the specific condition in the animal being treated, in particular to avoid unacceptable suffering, the veterinary surgeon may use their clinical judgement to treat animals under their care in accordance with the <a class="govuk-link" href="https://www.gov.uk/guidance/the-cascade-prescribing-unauthorised-medicines">cascade</a>. Ref. <a class="govuk-link" href="https://www.legislation.gov.uk/uksi/2013/2033/schedule/4" rel="external">The Veterinary Medicines Regulations 2013, Schedule 4</a>.</p>

<h2>
<span class="number">5. </span>Centrally Authorised Product (CAP)</h2>
<p>A product for which the marketing authorisation is granted, in accordance with Regulation (EC) No 726/2004, by the European Commission, and once granted is valid in all European Union and EFTA States (Iceland, Liechtenstein and Norway) and Northern Ireland.</p>

<h2>
<span class="number">6. </span>Clinical Trial</h2>
<p>A single scientific experiment conducted in a target species to test at least one hypothesis relevant to the proposed effectiveness claim(s) or to in-use safety in the target animal for a veterinary product under investigation.</p>

<h2>
<span class="number">7. </span>Competent Authority (CA)</h2>
<p>An authority responsible for the granting of marketing authorisations for medicinal products and the supervision of marketing of such products in accordance with the relevant laws and regulations established under applicable law.</p>

<h2>
<span class="number">8. </span>Data Lock Point (DLP)</h2>
<p>A cut-off date for data to be included in a PSUR. It may be set according to the European birth date or International birth date of the medicinal product. The MAH should in any case submit the PSUR no later than 60 days after the DLP.</p>

<h2>
<span class="number">9. </span>Detailed Description of a Pharmacovigilance System (DDPS)</h2>

<p>Document by which the applicant describes the pharmacovigilance system he/she intends to put in place. It is to be included in the Marketing Authorisation Application.</p>

<h2>
<span class="number">10. </span>EU Birth Date (EBD)</h2>
<p>The date of the first marketing authorisation within the European Union.</p>

<h2>
<span class="number">11. </span>The European Medicines Agency (EMA)</h2>
<p>A decentralised scientific body of the European Union which is responsible for the protection and promotion of public and animal health, through the coordination of evaluation and supervision of centrally authorised medicinal products for human and veterinary use. Ref. The Veterinary Medicines Regulations 2013, Part 1.</p>

<h2>
<span class="number">12. </span>Expedited report</h2>
<p>A report of a serious adverse reaction, human adverse reaction or unintended transmission of an infectious agent through a veterinary medicine following administration of the product in the UK submitted within 15 days following receipt of the information in accordance with the Veterinary Medicines Regulations 2013, Schedule 1, Part 8, paragraph 57. In addition, a serious unexpected adverse reaction, human adverse reaction or unintended transmission of an infectious agent through a veterinary medicine following administration of the product in a country outside the UK must also be expedited and reported within 15 days Ref. <a class="govuk-link" href="https://www.legislation.gov.uk/uksi/2013/2033/schedule/1/part/8" rel="external">The Veterinary Medicines Regulations 2013, Schedule 1, Part 8, paragraph 58</a>.</p>

<h2>
<span class="number">13. </span>Harmonised Birth Date (HBD)</h2>
<p>A Birth Date agreed amongst MS and industry for one specific product participating in the MS work share initiative on PSUR assessments.</p>

<h2>
<span class="number">14. </span>Human adverse reaction</h2>
<p>A reaction that is noxious and unintended and that occurs in a human being following exposure to a veterinary medicine. Ref. <a class="govuk-link" href="https://www.legislation.gov.uk/uksi/2013/2033/schedule/1/part/8" rel="external">The Veterinary Medicines Regulations 2013, Schedule 1, Part 8, paragraph 57(5)</a>. This guidance will not include the word “suspected” when making full text reference to human adverse reactions.</p>

<h2>
<span class="number">15. </span>International Birth Date (IBD)</h2>
<p>The date of the first marketing authorization for a same or similar product granted anywhere in the world, including any VICH region.</p>

<h2>
<span class="number">16. </span>International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH)</h2>
<p>A trilateral (EU-Japan-USA) programme aimed at harmonising technical requirements for veterinary product registration.</p>

<h2>
<span class="number">17. </span>Lack of expected efficacy</h2>
<p>The apparent inability of an authorised product to have the expected efficacy in an animal, according to the claims of the SPC and following use of the product in accordance with the SPC. This guidance will not include the word ‘suspected’ when making full text reference to lack of expected efficacy.</p>

<h2>
<span class="number">18. </span>Marketing Authorisation (MA)</h2>
<p>A decision given either by the European Commission, under centralised procedure, or by national competent authorities under national procedures, including decentralised and mutual recognition procedures, authorising the placing on the market of the veterinary medicine, in accordance with <a class="govuk-link" href="https://www.legislation.gov.uk/uksi/2013/2033/part/2" rel="external">The Veterinary Medicines Regulations 2013 Part 2, Regulation 4)</a>.</p>

<h2>
<span class="number">19. </span>Marketing Authorisation Holder (MAH)</h2>
<p>A person or entity who/which holds the authorisation of a veterinary medicine.</p>

<h2>
<span class="number">20. </span>National Competent Authority (NCA)</h2>
<p>The Competent Authority of a country having the responsibility for the evaluation and authorisation of MAs. In the UK this is the Veterinary Medicines Directorate (VMD) for veterinary medicines.</p>

<h2>
<span class="number">21. </span>Off-label use</h2>
<p>The use of a veterinary medicine that is not in accordance with the SPC, including the misuse and serious abuse of the product.</p>

<h2>
<span class="number">22. </span>Post-marketing surveillance studies</h2>
<p>Pharmacoepidemiological study or a clinical trial carried out in accordance with the terms of the marketing authorisation, conducted with the aim of identifying and investigating a safety hazard relating to an authorised veterinary medicine. Ref. <a class="govuk-link" href="https://www.legislation.gov.uk/uksi/2013/2033/schedule/1/part/8" rel="external">The Veterinary Medicines Regulations 2013, Schedule 1, Part 8, paragraph 56</a>.</p>

<h2>
<span class="number">23. </span>Primary data</h2>
<p>Data transmitted from the original reporter to a MAH or the VMD.</p>

<h2>
<span class="number">24. </span>Pharmacovigilance System Master File (PSMF)</h2>
<p>A detailed description of the pharmacovigilance system used by the marketing authorisation holder with respect to one or more authorised veterinary medicinal products.</p>

<h2>
<span class="number">25. </span>Periodic Safety Update Report (PSUR)</h2>
<p>A periodical scientific report on adverse events and other issues within the scope of pharmacovigilance that have been reported to a MAH during a specific period. Ref. <a class="govuk-link" href="https://www.legislation.gov.uk/uksi/2013/2033/schedule/1/part/8" rel="external">The Veterinary Medicines Regulations 2013, Schedule 1, Part 8, paragraph 59</a>.</p>

<h2>
<span class="number">26. </span>PSUR, abridged</h2>
<p>A PSUR that contains less information than a full PSUR and that contains only administrative data, and which has been prepared for a non-marketed product for which no reports have been received during the period.</p>

<h2>
<span class="number">27. </span>Serious adverse event</h2>
<p>Any adverse event which results in death, is life-threatening, results in persistent or significant disability/incapacity, or a congenital anomaly or birth defect. For animals managed and treated as a group, only an increased incidence of serious adverse events as defined above exceeding the rates normally expected in that particular group is considered a serious adverse event. Ref. <a class="govuk-link" href="https://vichsec.org/en/guidelines/pharmacovigilance/vich-gls-24-29-35-42.html" rel="external">VICH GL 24</a> (Pharmacovigilance: AERs). See also definition for “Animals managed and treated as a group”.</p>

<h2>
<span class="number">28. </span>Serious adverse reaction</h2>
<p>An adverse reaction which results in death, is life-threatening, results in significant disability or incapacity, is a congenital anomaly/birth defect, or which results in permanent or prolonged signs in the animals treated. Ref. <a class="govuk-link" href="https://www.legislation.gov.uk/uksi/2013/2033/schedule/1/part/8" rel="external">The Veterinary Medicines Regulations 2013, Schedule 1, Part 8, paragraph 57</a>. Life-threatening in this context refers to a reaction in which the animal was at risk of death at the time of the reaction. See also definition for “animals managed and treated as a group”.</p>

<h2>
<span class="number">29. </span>Summary of Product Characteristics (SPC)</h2>
<p>A document that contains the information on the condition of use of a veterinary medicine as developed during the course of the assessment process. Ref. <a class="govuk-link" href="https://www.legislation.gov.uk/uksi/2013/2033/schedule/1/part/1" rel="external">The Veterinary Medicines Regulations 2013, Schedule 1, Part 1, paragraph 3</a>.</p>

<h2>
<span class="number">30. </span>Unexpected adverse event</h2>
<p>An unexpected adverse event is an adverse event of which the nature, severity or outcome is not consistent with approved labelling or approved documents describing expected adverse events for a veterinary medicine. Ref. <a class="govuk-link" href="https://vichsec.org/en/guidelines/pharmacovigilance/vich-gls-24-29-35-42.html" rel="external">VICH GL 24</a> (Pharmacovigilance: AERs).</p>

<h2>
<span class="number">31. </span>Unexpected adverse reaction</h2>
<p>An adverse reaction is unexpected if its nature, severity or outcome  is not consistent with the summary of product characteristics. Ref. <a class="govuk-link" href="https://www.legislation.gov.uk/uksi/2013/2033/schedule/1/part/8" rel="external">The Veterinary Medicines Regulations 2013, Schedule 1, Part 8, paragraph 58</a>.</p>

<h2>
<span class="number">32. </span>Veterinary Dictionary for Drug Regulatory Activities (VeDDRA)</h2>
<p>A list of standard clinical terms to be used in reporting suspected adverse events in animals or humans after exposure to veterinary medicinal products.</p>

<h2>
<span class="number">33. </span>Veterinary Medicine</h2>
<p>Any substance or combination of substances, in accordance with <a class="govuk-link" href="https://www.legislation.gov.uk/uksi/2013/2033/part/1" rel="external">The Veterinary Medicines Regulations 2013, Part 1</a>, presented as having properties for treating or preventing disease in animals; or that may be used in or administered to animals with a view either to restoring, correcting or modifying physiological functions by exerting a pharmacological, immunological or metabolic action, or to making a medical diagnosis.</p>
</div>


</div>
</div>
  </div>

  <div class="sticky-element" data-sticky-element="">
    <a class="govuk-link app-c-back-to-top dont-print" href="#contents">
    <svg class="app-c-back-to-top__icon" focusable="false" height="17" viewBox="0 0 13 17" width="13" xmlns="http://www.w3.org/2000/svg">
      <path d="M6.5 0L0 6.5 1.4 8l4-4v12.7h2V4l4.3 4L13 6.4z" fill="currentColor"></path>
    </svg>
    Contents
</a>

    <div class="sticky-element__print-link">
      
<div class="gem-c-print-link govuk-!-display-none-print govuk-!-margin-top-0 govuk-!-margin-bottom-6">
    <button class="govuk-link govuk-body-s gem-c-print-link__button" data-module="print-link">Print this page</button>
</div>
    </div>
  </div>
</div>

    </main>